Business Wire01.09.18
SELVAS AI, an artificial intelligence (AI) company, is unveiling the world's first AI disease prediction service at CES (Consumer Electronics Show) 2018 this week in Las Vegas, Nev.
SELVAS AI is exhibiting “Selvy Checkup,” its AI disease prediction service, through an experience zone where visitors can try the service for themselves.
“Selvy Checkup” is a deep learning based medical service that predicts the probabilities of incidence within four years for six most common cancers including lung and liver cancers and major adult diseases including cardio-cerebrovascular disease and diabetes. It is provided as part of health checkup.
The service has attracted attention from medical, healthcare and wellness industries for the originality of its technology which does not simply diagnose diseases but forecasts the probabilities of disease outbreaks by using artificial intelligence techniques. The innovativeness and originality of “Selvy Checkup” were recognized in November 2017 when it was named winner of the “CES 2018 Innovations Awards” for the first time for an AI company.
“Selvy Checkup is an unrivaled AI healthcare service that enables users to manage their health proactively. As interest in healthy life is rising, we are convinced we will take market leadership with Selvy Checkup,” SELVAS AI CEO James Kim said.
SELVAS AI is an artificial intelligence company that conducts AI-related businesses in diverse fields including medical care, finance, automobiles, and assistive technology on the basis of machine learning techniques. It possesses core AI technologies such as voice, handwriting and image intelligences, and AI convergence technology, which combines those core technologies. All the technologies of SELVAS AI are based on machine learning platform.
SELVAS AI is exhibiting “Selvy Checkup,” its AI disease prediction service, through an experience zone where visitors can try the service for themselves.
“Selvy Checkup” is a deep learning based medical service that predicts the probabilities of incidence within four years for six most common cancers including lung and liver cancers and major adult diseases including cardio-cerebrovascular disease and diabetes. It is provided as part of health checkup.
The service has attracted attention from medical, healthcare and wellness industries for the originality of its technology which does not simply diagnose diseases but forecasts the probabilities of disease outbreaks by using artificial intelligence techniques. The innovativeness and originality of “Selvy Checkup” were recognized in November 2017 when it was named winner of the “CES 2018 Innovations Awards” for the first time for an AI company.
“Selvy Checkup is an unrivaled AI healthcare service that enables users to manage their health proactively. As interest in healthy life is rising, we are convinced we will take market leadership with Selvy Checkup,” SELVAS AI CEO James Kim said.
SELVAS AI is an artificial intelligence company that conducts AI-related businesses in diverse fields including medical care, finance, automobiles, and assistive technology on the basis of machine learning techniques. It possesses core AI technologies such as voice, handwriting and image intelligences, and AI convergence technology, which combines those core technologies. All the technologies of SELVAS AI are based on machine learning platform.